Fraser Alexander has served on the Retina International Management Committee since 2006. He was a member of the Retina NZ Executive Committee 1998-2016, holding the office of president 2007- 2016. Fraser holds a BSc in Pharmacology and Chemistry from the University of Auckland and a Masters Degree in Business with honours from the Auckland University of Technology. His current role involves working with people who have included the University of Auckland in their will, by helping to form mutually-beneficial relationships between bequestors and the University.
Hutokshi Chinoy is the Chief Administrator of the New Zealand National Eye Centre, which encompasses more than 120 ophthalmologists, vision scientists, optometrists and research staff. She also provides secretarial and administrative support to the Head of Department of Ophthalmology and senior academic staff at the University of Auckland. She has a Bachelor of Commerce degree and has been working in the ophthalmology department since 2004. She has been involved in coordinating and organising national and international scientific conferences and research seminars.
Professor Colin R Green
Cell biologist Colin Green obtained his PhD at the University of Auckland in 1980, then worked for 12 years in England, France and the United States before returning to New Zealand in 1993. He obtained his DSc in 1997 and a Personal Chair in Anatomy with Radiology at The University of Auckland in 2004. In 2005 he became the inaugural W & B Hadden Chair of Ophthalmology and Translational Vision Research. He has published over 160 research articles with two papers in Nature and one in Science. In 2004 he co-founded CoDaTherapeutics (NZ) Ltd where he remains Chairman. In 2006 he went on to co-found CoDa Therapeutics, Inc. San Diego, where he was on the board of directors until July 2012. During his time on the board the company raised US$70 Million to translate Colin’s gap junction channel modulation work into clinical application. Colin’s focus is on gap junction channel modulation for the treatment of chronic and inflammatory disease conditions in the eye and central nervous system, and the development of a new approach to cancer therapy.
Zoë Hill served on the Retina NZ Executive Committee from 2013-2016 and was the editor of the committee’s quarterly newsletter. She has a Bachelor’s degree in English Literary Theory and German from the University of Canterbury. Having been diagnosed with Retinitis Pigmentosa, she has developed a passion for web accessibility standards, especially for the sight impaired. Zoë keeps a close watch on emerging technologies, scientific breakthroughs and the arts and culture world. Prior to becoming a mother of 2 toddlers, Zoe had a successful career working with museum and art gallery databases; focusing on design, testing and documentation. She also trains museum and gallery staff and has organised workshops and large scale meetings in Australia, the UK and NZ.
Professor Charles McGhee
Charles McGhee graduated from the University of Glasgow with a Bachelor of Science in 1981, before completing his medical degree at the University of Glasgow in 1983. He went on to obtain a Fellowship of the Royal College of Physicians and Surgeons (FRCS) in Ophthalmology in 1988, an FRCOphth in 1989, and a PhD in Philosophy from the University of Dundee in 1989. He was awarded the FRANZCO in 1999, and became a Doctor of Science by Thesis (DSc) at the University of Auckland in 2014.
Professor McGhee has wide-ranging research interests with a focus on clinical or translational research. He is a leading expert in Corneal Disease and the treatment modalities for it. He has received more than $16,200,000 in research funding and has published more than 250 full paper and chapter publications, including three textbooks. He has been invited to give more than 100 lectures to learned societies, and has provided more than 100 free papers.
Sue Raynel is currently the department’s Research and Development Manager, and manager of NZ-NEC. She holds a nursing qualification as well as an MA. She has more than 20 years’ experience in ophthalmic practice, encompassing a wide range of roles in the hospital setting prior to taking up her current position at the University. Sue has been involved in the organisation of several large nursing conferences in conjunction with the RANZCO meetings.
Associate Professor Andrea Vincent MBChB, MD, FRANZCO
Dr Vincent is a Consultant Ophthalmologist at Greenlane Eye Clinic, and a Senior Lecturer in the Department of Ophthalmology at the University of Auckland, having trained in New Zealand with subsequent Genetic Ophthalmology in Melbourne and Toronto. She leads an Ocular Genetic laboratory facility with research underway into the genetics of retinal and corneal dystrophies, keratoconus, glaucoma and lid abnormalities. Dr Vincent established the NZ Inherited retinal disease database which has over 500 participants, and research includes functional characterisation of novel genetic mechanisms using a zebrafish model. She has 56 publications, and 2 book chapters, is an examiner for the Royal Australia and New Zealand College of Ophthalmologists, on the Editorial board of Ophthalmic genetics and Orphanet Journal of rare diseases, Section Editor for Clinical and Experimental Ophthalmology, and on the Board of the Ophthalmic Research Institute of Australia.
Dr Hannah Kersten
Hannah completed her Bachelor of Optometry degree with first class honours in 2008 and went on to work in a large community optometry practice. In 2016, Hannah completed her doctoral studies in the Department of Ophthalmology at the University of Auckland. Hannah’s main area of research interest is the potential role of optic nerve and retinal measures as biomarkers of disease progression in neurodegenerative disorders. Since 2016, Hannah has held a joint appointment as a lecturer in the School of Optometry and Vision Science, and as a Research Fellow in the Department of Ophthalmology, at the University of Auckland. Hannah’s research has been published in leading neurology journals, and she has presented the results of her research at a number of national and international conferences. In addition, Hannah continues to work in glaucoma and neuro-ophthalmology co-management in private practice.